ENOB News and Press, Enochian Biosciences Inc. From 06/14/21

Enochian BioSciences (ENOB) shares skyrocket to more than double their value during the premarket session after the U.S. FDA accepted a Pre-IND ((Investigational New Drug)) request for a potential functional cure or treatment of HIV.The request was based on the results of a 54-year old man li...

LOS ANGELES, June 14, 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that the FDA has accepted a Pre-IND (Investigational New Drug) request for a potential functional cu...

Enochian BioSciences ([[ENOB]] +7.3%) announces the release of preliminary data relating to the use of a novel cell therapy approach in controlling HIV in humans.The findings were presented at the Annual Meeting of the American Society of Gene and Cell Therapy ((ASGCT)).A 54-year-old man, dia...

A Promising Approach To HIV Cell Therapy, With Exciting Preliminary Results, Was Presented Recently At The Leading Conference On Gene And Cell Therapy PR Newswire LOS ANGELES , May 12, 2021 /PRNewswire/ -- (NASDAQ: ENOB) –  A novel approach to HI...

LOS ANGELES, May 12, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced the release of preliminary data relating to the use of a novel cell therapy a...

Enochian Biosciences is tackling some difficult areas of biotech with innovative treatment types. The company is attempting to develop a cure for HIV, Hepatitis B and extending remission in difficult to treat cancers including pancreatic cancer. None of the company's assets have e...

Enochian BioSciences (ENOB), up 29% premarket and Seraph Research Institute ((SRI)) announce that a 36-year old patient with recurrent glioblastoma achieved complete remission for a period of 15 months. A complete remission response such as this is uncommon for this highly aggressiv...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning and welcome to the stock market today! If you want to be prepared for a busy day of trading, make sure you take a look at the top pre-market movers. Source: Shutterstock Want more insight? Dive in wi...

LOS ANGELES, March 24, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Seraph Research Institute (SRI) and Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that a 36-year old patient with recurre...

The following slide deck was published by Enochian Biosciences, Inc. in conjunction with this event. For further details see: Enochian Biosciences (ENOB) Presents At H.C. Wainwright Global Life Sciences Conference